Sum of ST-segment elevations on admission electrocardiograms in acute myocardial infarction predicts left ventricular dilation

American Journal of Cardiology

Volumn 77, Issue 14, 1996, Pages 1237-1241

  Nixdorff, Uwe ^a   Erbel, Raimund ^a   Rupprecht, Hans Jürgen ^a   Rill, Markus ^a   Spiecker, Martin ^a   Meyer, Jürgen ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEART ENZYME;

ADULT; AGED; ARTICLE; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION;

EID: 0029978934     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00172-5     Document Type: Article

References (19)

1. Nixdorff U, Erbel R, Pop T, Rupprecht H-J, Henrichs K-J, Mörchen S, Meyer J. Long-term follow-up of global and regional left ventricular function by two-dimensional echocardiography after thrombolytic therapy in acute myocardial infarction. Int J Cardiol 1993;41:31-47.
2. Erbel R, Pop T, Henrichs K-J, von Olshausen K, Schuster CJ, Rupprecht H-J, Steuernagel C, Meyer J. Percutaneous transluminal coronary angioplasty after thrombolytic therapy: a prospective controlled randomized trial. J Am Coll Cardiol 1986;8:485-495.
3. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardio. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994;343:1115-1122.
4. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet 1995;345:669-685.
5. Konstan MA, Kronenberg MW, Rousseau MF, for the SOLVD Investigators. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. Circulation 1993;88:2277-2283.
6. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH, Hawkins CM, on behalf of the SAVE-Investigators. Effects of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992;327:669-677.
7. Pardee HEB. An electrocardiograpbic sign of coronary artery obstruction. Arch Intern Med 1920;26:244-253.
8. Christian TF, Clements IP, Behrenbeck T, Huber KC, Chesebro JH, Gersh BJ, Gibbons RJ. Limitations of the electrocardiogram in estimating infarction size after acute reperfusion therapy for myocardial infarction. Ann Intern Med 1991;114:264-270.
9. Yusuf S, Lopez R, Maddison A, Maw P, Ray N, McMillan S, Sleight P. Value of electrocardiogram in predicting and estimating infarct size in man. Br Heart J 1979;42:286-293.
10. Ross AM, for the TIMI Investigators. Electrocardiographic and angiographic correlations in myocardial infarction patients treated with thrombolytic agents: a report from the NHLBI Thrombolysis in Myocardial Infarction (TIMI) trial. J Am Coll Cardiol 1985;2:495-502.
11. von Essen R, Schmidt W, Uebis R, Edelman B, Effert S, Sinly J, Rau G. Myocardial infarction and thrombolysis: electrocardiographic short term and long term results using precordial mapping. Br Heart J 1985;54: 6-10.
12. Savage RM, Wagner GS, Ideker RE, Podolsky SA, Hackel DB. Correlation of postmortem anatomic findings with electrocardiographic changes in patients with typical anterior and posterior infarcts. Circulation 1977;55:279-285.
13. Palmeri ST, Harrison DG, Cobb FR, Morris KG, Harrell FE, Ideker R, Selvester RH, Wagner GS. A QRS scoring system for assessing left ventricular function after myocardial infarction. N Engl J Med 1982;306:4-9.
14. Schaper J. Ultrastructural aspects of ischemia and reperfusion in canine and human heart. In: Effert S, von Essen R, eds. Thrombolysis: Facts and Hopes. Darmstadt, Germany: Steinkopff, 1986:1-53.
15. Vermeer F, Simoons ML, Bär FW, Tijssen JGP, van Domburg RT, Serruys PW, Verheugt FWA, Res JCJ, de Zwaan C, van der Laarse A, Krauss XH, Lubsen J, Hugenholtz PG. Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase? Circulation 1986;74:1379-1389.
16. Hindman N, Grande P, Harrell FE, Anderson C, Harrison D, Ideker RE, Selvester RH, Wagner GS. Relation between electrocardiographic and enzymatic methods of estimating acute myocardial infarct size. Am J Cardiol 1986;58:31-35.
17. Swedberg K, Held P, Kjekskes J, Rasmussen K, Rydin L, Wedel H, on behalf of the CONSENSUS II Study Group. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. N Engl J Med 1992;327:678-684.
18. Nabel EG, Topol EJ, Galeana A, Ellis SG, Bates ER, Werns SW, Walton JA, Muller DW, Schwaiger M, Pitt B. A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction. J Am Coll Cardiol 1991;17:467-473.
19. Kingma JH, van Gilst WH, Peels CH, Dambrink JH, Verheugt FW, Wielenga RP. Acute intervention with captopril during thrombolysis in patients with first anterior myocardial infarction: results from the Captopril and Thrombolysis Study (CATS). Eur Heart J 1994;15:898-907.